期刊文献+

渗透泵给药系统设计原理、关键技术与发展动态 被引量:22

The mechanism,critical technology and progress of osmotic drug delivery systems
暂未订购
导出
摘要 渗透泵控释制剂作为缓控释制剂的典型代表,是以渗透压为释药动力、以零级释放动力学为特征的一种制剂技术。由于其释药行为不受介质环境pH和食物等因素的影响,以及体内外释药相关性较好等特点,引起了国内外学者的广泛关注。经过多年的发展,渗透泵制剂的机制不断创新,结构不断完善,并已有多个产品上市。本文概述了渗透泵系统的发展历程及控释原理,并从药物溶解度、渗透压、释药孔及包衣膜4个方面,重点阐述影响渗透泵控释制剂药物释放速率的关键因素和国内外研发新进展。 As the typical example of controlled release preparation,osmotic pump-controlled release preparation is a new tech-nique of preparation characterized by zero order release kinetics.Osmotic pressure is the motivation for releasing drug.The release be-havior of osmotically controlled release systems is independent of external pH and food,and the in vivo-in vitro correlation is good,so they have attracted wide attention at home and abroad.After years of development,with the constant innovation of the mechanism,the structure of the osmotic pump has been continuously improved,and many products have been marketed.In this article,the develop-ment history and the mechanism of osmotic pump-controlled release preparation are briefly reviewed.Based on solubility,osmotic pres-sure,the delivery orifice and the coating membrane,the critical factors affecting the release rate and the research progress on osmotic pump controlled release preparation are mainly discussed.
作者 颜琨 梅兴国
出处 《国际药学研究杂志》 CAS 2010年第2期92-97,共6页 Journal of International Pharmaceutical Research
基金 国家科技重大专项--综合性新药研究开发技术大平台资助项目(2009ZX09301-002) 重大新药创制科技重大专项--军队特需药品保密专项(2008ZXJ09010-001)
关键词 渗透泵 控释系统 渗透压 半透膜 osmotic pumps controlled release systems osmotic pressure semipermeable membrane
  • 相关文献

参考文献31

  • 1Verma RK,Krishna DM,Garg S.Formulation aspects in the development of osmotically controlled oral drug delivery systems[J].J Control Release,2002,79(1-3):7-27.
  • 2Prabakaran D,Singh P,Kanaujia P,et al.Effect of hydrophilic polymers on the release of diltiazem hydrochloride from elementary osmotic pumps[J].Int J Pharm,2003,259(1/2):173-179.
  • 3Santus G,Baker RW.Osmotic drug delivery:a review of the patent literature[J].J Control Release,1995,35(1):1-21.
  • 4Rose S,Nelson JF.A continuous long-term injector[J].Aust J Exp Biol,1955,33(4):415-419.
  • 5Malaterre V,Ogorka J,Loggia N,et al.Oral osmotically driven systems:30 years of development and clinical use[J].Eur J Pharm Biopharm,2009,73(3):311-323.
  • 6Makhija SN,Vavia PR.Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine Ⅰ.Cellulose acetate as a semipermeable membrane[J].J Control Release,2003,89(1):5-18.
  • 7陈志鹏,朱家壁.口服渗透泵制剂的研究进展[J].国外医学(药学分册),2005,32(2):87-91. 被引量:15
  • 8Liu LX,Khang G,Rhee JM,et al.Monolithic osmotic tablet system for nifedipine delivery[J].J Control Release,2000,67(2/3):309-322.
  • 9Liu LX,Ku J,Khang G,et al.Nifedipine controlled delivery by sandwiched osmotic tablet system[J].J Control Release,2000,68(2):145-156.
  • 10Prabakaran D,Singh P,Kanaujia P,et al.Modified push-pull osmotic system for simultaneous delivery of theophylline and salbutamol:development and in vitro characterization[J].Int J Pharm,2004,284(1/2):95-108.

二级参考文献106

共引文献66

同被引文献262

引证文献22

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部